Cargando…

Locoregional therapy with α‐emitting trastuzumab against peritoneal metastasis of human epidermal growth factor receptor 2‐positive gastric cancer in mice

Peritoneal metastasis of gastric cancer (PMGC) is incurable and thus has an extremely poor prognosis. We have found, however, that locoregionally administered trastuzumab armed with astatine‐211 ((211)At‐trastuzumab) is effective against human epidermal growth factor receptor 2 (HER2)‐positive PMGC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Huizi Keiko, Morokoshi, Yukie, Nagatsu, Kotaro, Kamada, Tadashi, Hasegawa, Sumitaka
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2017
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5543454/ https://www.ncbi.nlm.nih.gov/pubmed/28514062 http://dx.doi.org/10.1111/cas.13282

Ejemplares similares

Evidence of Local Concentration of α-Particles from (211)At-Labeled Antibodies in Liver Metastasis Tissue
por: Kodaira, Satoshi, et al.
Publicado: (2019)

α‐particle therapy for synovial sarcoma in the mouse using an astatine‐211‐labeled antibody against frizzled homolog 10
por: Li, Huizi Keiko, et al.
Publicado: (2018)

Significance of PD-L1 expression in carbon-ion radiotherapy for uterine cervical adeno/adenosquamous carcinoma
por: Iijima, Moito, et al.
Publicado: (2019)

Validating α-particle emission from (211)At-labeled antibodies in single cells for cancer radioimmunotherapy using CR-39 plastic nuclear track detectors
por: Kodaira, Satoshi, et al.
Publicado: (2017)

PU-H71, a novel Hsp90 inhibitor, as a potential cancer-specific sensitizer to carbon-ion beam therapy
por: Li, Huizi Keiko, et al.
Publicado: (2016)

Editorial: Peritoneal metastasis of gastric cancer
por: Wang, Shuyi, et al.
Publicado: (2023)

The Development of Peritoneal Metastasis from Gastric Cancer and Rationale of Treatment According to the Mechanism
por: Yonemura, Yutaka, et al.
Publicado: (2022)

In vitro cytotoxicity of Auger electron-emitting [(67)Ga]Ga-trastuzumab
por: Othman, Muhamad Faiz bin, et al.
Publicado: (2020)

Trastuzumab improves locoregional control in HER2-positive breast cancer patients following adjuvant radiotherapy
por: Cao, Lu, et al.
Publicado: (2016)

Pertuzumab and Trastuzumab Combination with Concomitant Locoregional Radiotherapy for the Treatment of Breast Cancers with HER2 Receptor Overexpression
por: Aboudaram, Amélie, et al.
Publicado: (2021)

Association of ERBB2 Copy Number and Gene Coalterations With Trastuzumab Efficacy and Resistance in Human Epidermal Growth Factor Receptor 2–Positive Esophagogastric and Gastric Cancer
por: Hino, Kaori, et al.
Publicado: (2022)

Lymph node metastases rate of locoregional and non-locoregional lymph node stations in gastric cancer
por: de Jong, Mees Hendrik Siert, et al.
Publicado: (2022)

Preclinical Evaluation of the Acute Radiotoxicity of the α-Emitting Molecular-Targeted Therapeutic Agent (211)At-MABG for the Treatment of Malignant Pheochromocytoma in Normal Mice
por: Sudo, Hitomi, et al.
Publicado: (2019)

Feasibility of carbon‐ion radiotherapy for re‐irradiation of locoregionally recurrent, metastatic, or secondary lung tumors
por: Hayashi, Kazuhiko, et al.
Publicado: (2018)

Issues on peritoneal metastasis of gastric cancer: an update
por: Wang, Zhen, et al.
Publicado: (2019)

In Vitro Evaluation of No-Carrier-Added Radiolabeled Cisplatin ([(189, 191)Pt]cisplatin) Emitting Auger Electrons
por: Obata, Honoka, et al.
Publicado: (2021)

Antitumor effects of radionuclide treatment using α-emitting meta-(211)At-astato-benzylguanidine in a PC12 pheochromocytoma model
por: Ohshima, Yasuhiro, et al.
Publicado: (2018)

Galectin-1 promotes gastric cancer peritoneal metastasis through peritoneal fibrosis
por: Shen, Xianhe, et al.
Publicado: (2023)

Durable Response of Human Epidermal Growth Factor Receptor-2-Positive Gastric Adenosquamous Carcinoma to Trastuzumab-Based Chemotherapy
por: Kadowaki, Shigenori, et al.
Publicado: (2014)

Discovering Biomarkers in Peritoneal Metastasis of Gastric Cancer by Metabolomics
por: Pan, Guoqiang, et al.
Publicado: (2020)

Macrophages on the Peritoneum are involved in Gastric Cancer Peritoneal Metastasis
por: Song, Hongjiang, et al.
Publicado: (2019)

CXCL8 and the peritoneal metastasis of ovarian and gastric cancer
por: Fu, Xuanrong, et al.
Publicado: (2023)

Primary Peritoneal Carcinosarcoma With Metastasis to the Umbilicus and Pancreas
por: Tanabe, Shohei, et al.
Publicado: (2022)

Autophagy flux inhibition augments gastric cancer resistance to the anti-human epidermal growth factor receptor 2 antibody trastuzumab
por: Ye, Hua, et al.
Publicado: (2018)

Dicer increases the indication for trastuzumab treatment in gastric cancer patients via overexpression of human epidermal growth factor receptor 2
por: Wu, Jianhua, et al.
Publicado: (2021)

Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
por: Durcker, Arik, et al.
Publicado: (2020)

Locoregional gastric cancer: a narrative review of multidisciplinary management
por: Pelcovits, Ari, et al.
Publicado: (2020)

Radiomics Nomogram for Prediction of Peritoneal Metastasis in Patients With Gastric Cancer
por: Huang, Weicai, et al.
Publicado: (2020)

Oncolytic Virotherapy in Peritoneal Metastasis Gastric Cancer: The Challenges and Achievements
por: Shao, Su, et al.
Publicado: (2022)

Prognostic Factors for Distant Metastasis in Patients with Locoregional Recurrence after Mastectomy
por: Jeong, Yuri, et al.
Publicado: (2015)

Correction to: Trastuzumab-induced upregulation of a protein set in extracellular vesicles emitted by ErbB2-positive breast cancer cells correlates with their trastuzumab sensitivity
por: Drucker, Arik, et al.
Publicado: (2020)

Anti‐epidermal growth factor receptor therapy concurrently with induction chemotherapy in locoregionally advanced nasopharyngeal carcinoma
por: Peng, Hao, et al.
Publicado: (2018)

Computed tomography-guided permanent brachytherapy for locoregional recurrent gastric cancer
por: Shi, Liangrong, et al.
Publicado: (2012)

u-PA inhibitor amiloride suppresses peritoneal metastasis in gastric cancer
por: Ding, Youcheng, et al.
Publicado: (2012)

Clinical significance of the uPA system in gastric cancer with peritoneal metastasis
por: Ding, Youcheng, et al.
Publicado: (2013)

Predicting Peritoneal Metastasis of Gastric Cancer Patients Based on Machine Learning
por: Zhou, Chengmao, et al.
Publicado: (2020)

Comprehensive Roles and Future Perspectives of Exosomes in Peritoneal Metastasis of Gastric Cancer
por: Chen, Xiangliu, et al.
Publicado: (2021)

Integration of Genomic Biology Into Therapeutic Strategies of Gastric Cancer Peritoneal Metastasis
por: Gwee, Yong Xiang, et al.
Publicado: (2022)

CT characteristics for predicting prognosis of gastric cancer with synchronous peritoneal metastasis
por: Li, Jiazheng, et al.
Publicado: (2023)

Cancer field surgery in endometrial cancer: peritoneal mesometrial resection and targeted compartmental lymphadenectomy for locoregional control
por: Buderath, Paul, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m64ink9o9kfi21v3pnb0n4k2mv